Browsing Bergen Open Research Archive by Author "Vickerman, Peter"
Now showing items 1-7 of 7
-
Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial
Lim, Aaron Guanliang; Aas, Christer Frode; Çağlar, Ege Su; Vold, Jørn Henrik; Fadnes, Lars T.; Vickerman, Peter; Johansson, Kjell Arne (Journal article; Peer reviewed, 2023)Background and aims The INTRO-HCV randomized controlled trial conducted in Norway over 2017–2019 found that integrated treatment, compared with standard-of-care hospital treatment, for hepatitis C virus (HCV) with ... -
Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders
Aas, Christer Frode; Vold, Jørn Henrik; Chalabianloo, Fatemeh; Løberg, Else-Marie; Lim, Aaron G.; Vickerman, Peter; Johansson, Kjell Arne; Fadnes, Lars T. (Journal article; Peer reviewed, 2024)People with substance use disorders (SUD) have a high prevalence of chronic hepatitis C virus (HCV) infection and mental health disorders. We aimed to assess the impact of integrated HCV treatment on psychological distress ... -
The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
Vold, Jørn Henrik; Chalabianloo, Fatemeh; Løberg, Else-Marie; Aas, Christer Frode; Lim, Aaron G.; Vickerman, Peter; Johansson, Kjell Arne; Fadnes, Lars T. (Journal article; Peer reviewed, 2023)Background Most people who inject drugs (PWIDs) suffer from severe fatigue, and chronic hepatitis C virus (HCV) infection may play a role in this. However, there is scarce evidence about interventions that alleviate ... -
Integrated care of severe infectious diseases to people with substance use disorders; a systematic review
Vold, Jørn Henrik; Aas, Christer Frode; Leiva, Rafael Alexander Mo; Vickerman, Peter; Chalabianloo, Fatemeh; Løberg, Else-Marie; Johansson, Kjell Arne; Fadnes, Lars T. (Peer reviewed; Journal article, 2019)Background: Various integrated care models have been used to improve treatment completion of medications for chronic hepatitis B virus (HBV), chronic hepatitis C virus (HCV), Mycobacterium tuberculosis (TB), and Human ... -
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
Fadnes, Lars T.; Aas, Christer Frode; Vold, Jørn Henrik; Leiva, Rafael Alexander Mo; Ohldieck, Christian; Chalabianloo, Fatemeh; Skurtveit, Svetlana Ondrasova; Lygren, Ole Jørgen; Dalgard, Olav; Vickerman, Peter; Midgard, Håvard; Løberg, Else-Marie; Johansson, Kjell Arne (Journal article; Peer reviewed, 2021)Background The standard pathways of testing and treatment for hepatitis C virus (HCV) infection in tertiary healthcare are not easily accessed by people who inject drugs (PWID). The aim of this study was to evaluate the ... -
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
Fadnes, Lars T.; Aas, Christer Frode; Vold, Jørn Henrik; Ohldieck, Christian; Leiva, Rafael Alexander Mo; Chalabianloo, Fatemeh; Skurtveit, Svetlana; Lygren, Ole Jørgen; Dalgard, Olav; Vickerman, Peter; Midgard, Håvard; Løberg, Else-Marie; Johansson, Kjell Arne (Peer reviewed; Journal article, 2019-11-08)Background: A large proportion of people who inject drugs (PWID) living with hepatitis C virus (HCV) infection have not been treated. It is unknown whether inclusion of HCV diagnostics and treatment into integrated substance ... -
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: A prospective cohort study from 2013 to 2017
Aas, Christer Frode; Vold, Jørn Henrik; Skurtveit, Svetlana; Odsbu, Ingvild; Chalabianloo, Fatemeh; Økland, Jan-Magnus; Leiva, Rafael Alexander Mo; Vickerman, Peter; Johansson, Kjell Arne; Fadnes, Lars T. (Journal article; Peer reviewed, 2020)Objectives We aimed to calculate cumulative hepatitis C virus (HCV) treatment coverage among individuals enrolled in opioid agonist therapy (OAT) in Norway between 2013 and 2017 and to document the treatment transition to ...